{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:28:27Z","timestamp":1791296907934,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/nrmicro2048","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T23:59:19Z","timestamp":1229385559000},"page":"81-87","source":"Crossref","is-referenced-by-count":137,"title":["Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Christopher","family":"Dye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrmicro2048_CR1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0140-6736(06)68392-X","volume":"367","author":"MC Raviglione","year":"2006","unstructured":"Raviglione, M. C. & Uplekar, M. W. WHO's new stop TB strategy. Lancet 367, 952\u2013955 (2006).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR2","unstructured":"World Health Organization. Anti-tuberculosis drug resistance in the world: report no. 3 (WHO, Geneva, 2004)."},{"key":"BFnrmicro2048_CR3","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1371\/journal.pmed.0040050","volume":"4","author":"JA Singh","year":"2007","unstructured":"Singh, J. A., Upshur, R. & Padayatchi, N. XDR-TB in South Africa: no time for denial or complacency. PLoS Med. 4, e50 (2007).","journal-title":"PLoS Med."},{"key":"BFnrmicro2048_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1126\/science.319.5865.894","volume":"319","author":"R Koenig","year":"2008","unstructured":"Koenig, R. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination. Science 319, 894\u2013897 (2008).","journal-title":"Science"},{"key":"BFnrmicro2048_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.trstmh.2007.11.014","volume":"102","author":"KD Jones","year":"2008","unstructured":"Jones, K. D., Hesketh, T. & Yudkin, J. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern. Trans. R. Soc. Trop. Med. Hyg. 102, 219\u2013224 (2008).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnrmicro2048_CR6","unstructured":"World Health Organization. Anti-tuberculosis drug resistance in the world: report no. 4 (WHO, Geneva, 2008)."},{"key":"BFnrmicro2048_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0140-6736(08)60350-5","volume":"371","author":"A von Gottberg","year":"2008","unstructured":"von Gottberg, A. et al. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. Lancet 371, 1108\u20131113 (2008).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrd2223","volume":"6","author":"REW Hancock","year":"2007","unstructured":"Hancock, R. E. W. The end of an era? Nature Rev. Drug Discov. 6, 28 (2007).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrmicro2048_CR9","first-page":"1185","volume":"10","author":"M Raviglione","year":"2006","unstructured":"Raviglione, M. XDR-TB: entering the post-antibiotic era? Int. J. Tuberc. Lung Dis. 10, 1185\u20131187 (2006).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"BFnrmicro2048_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1473-3099(05)70086-4","volume":"5","author":"SR Norrby","year":"2005","unstructured":"Norrby, S. R., Nord, C. E. & Finch, R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis. 5, 115\u2013119 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrmicro2048_CR11","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1038\/nm1145","volume":"10","author":"SB Levy","year":"2004","unstructured":"Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nature Med. 10, S122\u2013S129 (2004).","journal-title":"Nature Med."},{"issue":"Suppl. 1","key":"BFnrmicro2048_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1086\/518663","volume":"196","author":"MK Spigelman","year":"2007","unstructured":"Spigelman, M. K. New tuberculosis therapeutics: a growing pipeline. J. Infect. Dis. 196 (Suppl. 1), 28\u201334 (2007).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2048_CR13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.1119299","volume":"311","author":"SW Glickman","year":"2006","unstructured":"Glickman, S. W., Rasiel, E. B., Hamilton, C. D., Kubataev, A. & Schulman, K. A. A portfolio model of drug development for tuberculosis. Science 311, 1246\u20131247 (2006).","journal-title":"Science"},{"key":"BFnrmicro2048_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1098\/rspb.2000.1328","volume":"268","author":"C Dye","year":"2001","unstructured":"Dye, C. & Espinal, M. A. Will tuberculosis become resistant to all antibiotics? Proc. R. Soc. Lond. B 268, 45\u201352 (2001).","journal-title":"Proc. R. Soc. Lond. B"},{"key":"BFnrmicro2048_CR15","unstructured":"World Health Organization. The global MDR-TB and XDR-TB response plan 2007\u20132008 (WHO, Geneva, 2007)."},{"key":"BFnrmicro2048_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1086\/339818","volume":"185","author":"C Dye","year":"2002","unstructured":"Dye, C., Espinal, M. A., Watt, C. J., Mbiaga, C. & Williams, B. G. Worldwide incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 185, 1197\u20131202 (2002).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2048_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/505877","volume":"194","author":"M Zignol","year":"2006","unstructured":"Zignol, M. et al. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 194, 479\u2013485 (2006).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2048_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1164\/rccm.200801-175PP","volume":"177","author":"T Cohen","year":"2008","unstructured":"Cohen, T. et al. Challenges in estimating the total burden of drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 177, 1302\u20131306 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrmicro2048_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3201\/eid1409.061524","volume":"14","author":"Y Ben Amor","year":"2008","unstructured":"Ben Amor, Y., Nemser, B., Singh, A., Sankin, A. & Schluger, N. Underreported threat of multidrug-resistant tuberculosis in Africa. Emerg. Infect. Dis. 14, 1345\u20131352 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrmicro2048_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3201\/eid1303.061400","volume":"13","author":"NS Shah","year":"2007","unstructured":"Shah, N. S. et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13, 380\u2013387 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrmicro2048_CR21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1086\/522987","volume":"45","author":"M Pillay","year":"2007","unstructured":"Pillay, M. & Sturm, A. W. Evolution of the extensively drug-resistant F15\/LAM4\/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin. Infect. Dis. 45, 1409\u20131414 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2048_CR22","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"NR Gandhi","year":"2006","unstructured":"Gandhi, N. R. et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368, 1575\u20131580 (2006).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1098\/rspb.2000.1328","volume":"268","author":"C Dye","year":"2001","unstructured":"Dye, C. & Espinal, M. A. Will tuberculosis become resistant to all antibiotics? Proc. R. Soc. Lond. B 268, 45\u201352 (2001).","journal-title":"Proc. R. Soc. Lond. B"},{"key":"BFnrmicro2048_CR24","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.1073\/pnas.140102797","volume":"97","author":"C Dye","year":"2000","unstructured":"Dye, C. & Williams, B. G. Criteria for the control of drug-resistant tuberculosis. Proc. Natl Acad. Sci. USA 97, 8180\u20138185 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2048_CR25","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1126\/science.1063814","volume":"295","author":"C Dye","year":"2002","unstructured":"Dye, C., Williams, B. G., Espinal, M. A. & Raviglione, M. C. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295, 2042\u20132046 (2002).","journal-title":"Science"},{"key":"BFnrmicro2048_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1473-3099(03)00483-3","volume":"3","author":"T Cohen","year":"2003","unstructured":"Cohen, T., Sommers, B. & Murray, M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect. Dis. 3, 13\u201321 (2003).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrmicro2048_CR27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nrmicro1796","volume":"5","author":"JL Martinez","year":"2007","unstructured":"Martinez, J. L., Baquero, F. & Andersson, D. I. Predicting antibiotic resistance. Nature Rev. Microbiol. 5, 958\u2013965 (2007).","journal-title":"Nature Rev. Microbiol."},{"key":"BFnrmicro2048_CR28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/molbev\/msj120","volume":"23","author":"V Rosas-Magallanes","year":"2006","unstructured":"Rosas-Magallanes, V. et al. Horizontal transfer of a virulence operon to the ancestor of Mycobacterium tuberculosis. Mol. Biol. Evol. 23, 1129\u20131135 (2006).","journal-title":"Mol. Biol. Evol."},{"key":"BFnrmicro2048_CR29","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1128\/JB.00009-08","volume":"190","author":"A Coros","year":"2008","unstructured":"Coros, A., DeConno, E. & Derbyshire, K. M. IS6110, a Mycobacterium tuberculosis complex-specific insertion sequence, is also present in the genome of Mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial species. J. Bacteriol. 190, 3408\u20133410 (2008).","journal-title":"J. Bacteriol."},{"key":"BFnrmicro2048_CR30","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1093\/molbev\/msm111","volume":"24","author":"J Becq","year":"2007","unstructured":"Becq, J. et al. Contribution of horizontally acquired genomic islands to the evolution of the tubercle bacilli. Mol. Biol. Evol. 24, 1861\u20131871 (2007).","journal-title":"Mol. Biol. Evol."},{"key":"BFnrmicro2048_CR31","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1128\/AAC.00112-06","volume":"50","author":"MH Hazbon","year":"2006","unstructured":"Hazbon, M. H. et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50, 2640\u20132649 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro2048_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1469-0691.2008.01951.x","volume":"14","author":"T Prammananan","year":"2008","unstructured":"Prammananan, T. et al. Distribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for mutation detection. Clin. Microbiol. Infect. 14, 446\u2013453 (2008).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnrmicro2048_CR33","doi-asserted-by":"publisher","first-page":"e1000034","DOI":"10.1371\/journal.ppat.1000034","volume":"4","author":"M Caws","year":"2008","unstructured":"Caws, M. et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 4, e1000034 (2008).","journal-title":"PLoS Pathog."},{"key":"BFnrmicro2048_CR34","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","volume":"283","author":"MA Espinal","year":"2000","unstructured":"Espinal, M. A. et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. J. Am. Med. Assoc. 283, 2537\u20132545 (2000).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnrmicro2048_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1164\/rccm.200802-240OC","volume":"178","author":"A Mak","year":"2008","unstructured":"Mak, A. et al. Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. Am. J. Respir. Crit. Care Med. 178, 306\u2013312 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrmicro2048_CR36","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1371\/journal.pmed.0030384","volume":"3","author":"H Cox","year":"2006","unstructured":"Cox, H. et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med. 3, e384 (2006).","journal-title":"PLoS Med."},{"key":"BFnrmicro2048_CR37","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1086\/517536","volume":"44","author":"HS Cox","year":"2007","unstructured":"Cox, H. S. et al. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin. Infect. Dis. 44, 1421\u20131427 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2048_CR38","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3201\/eid1209.051618","volume":"12","author":"E Nathanson","year":"2006","unstructured":"Nathanson, E. et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg. Infect. Dis. 12, 1389\u20131397 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrmicro2048_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(05)70196-3","volume":"365","author":"V Leimane","year":"2005","unstructured":"Leimane, V. et al. Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 365, 318\u2013326 (2005).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MCP.0b013e3280f3c0b2","volume":"13","author":"J Furin","year":"2007","unstructured":"Furin, J. The clinical management of drug-resistant tuberculosis. Curr. Opin. Pulm. Med. 13, 212\u2013217 (2007).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"BFnrmicro2048_CR41","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3201\/eid1204.041256","volume":"12","author":"SS Shin","year":"2006","unstructured":"Shin, S. S. et al. Long-term follow-up for multidrug-resistant tuberculosis. Emerg. Infect. Dis. 12, 687\u2013688 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrmicro2048_CR42","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(08)61204-0","volume":"372","author":"S Keshavjee","year":"2008","unstructured":"Keshavjee, S. et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 372, 1403\u20131409 (2008).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1056\/NEJMoa0800106","volume":"359","author":"CS Mitnick","year":"2008","unstructured":"Mitnick, C. S. et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N. Engl. J. Med. 359, 563\u2013574 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2048_CR44","unstructured":"World Health Organization. Global tuberculosis control 2008: surveillance, planning, financing (WHO, Geneva, 2008)."},{"key":"BFnrmicro2048_CR45","unstructured":"World Health Organization. Green Light Committee Initiative. Annual report (WHO, Geneva, 2007)."},{"key":"BFnrmicro2048_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1086\/590005","volume":"47","author":"YS Kwon","year":"2008","unstructured":"Kwon, Y. S. et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin. Infect. Dis. 47, 496\u2013502 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2048_CR47","doi-asserted-by":"crossref","first-page":"e2957","DOI":"10.1371\/journal.pone.0002957","volume":"3","author":"CA Bonilla","year":"2008","unstructured":"Bonilla, C. A. et al. Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS One 3, e2957 (2008).","journal-title":"PLoS One"},{"key":"BFnrmicro2048_CR48","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/bmj.39463.640787.BE","volume":"336","author":"HS Cox","year":"2008","unstructured":"Cox, H. S., Morrow, M. & Deutschmann, P. W. Long term efficacy of DOTS regimens for tuberculosis: systematic review. Br. Med. J. 336, 484\u2013487 (2008).","journal-title":"Br. Med. J."},{"key":"BFnrmicro2048_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMc0706556","volume":"359","author":"ED Chan","year":"2008","unstructured":"Chan, E. D., Strand, M. J. & Iseman, M. D. Treatment outcomes in extensively resistant tuberculosis. N. Engl. J. Med. 359, 657\u2013659 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2048_CR50","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/AAC.48.4.1289-1294.2004","volume":"48","author":"DH Mariam","year":"2004","unstructured":"Mariam, D. H., Mengistu, Y., Hoffner, S. E. & Andersson, D. I. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48, 1289\u20131294 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro2048_CR51","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1126\/science.1124410","volume":"312","author":"S Gagneux","year":"2006","unstructured":"Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944\u20131946 (2006).","journal-title":"Science"},{"key":"BFnrmicro2048_CR52","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1128\/JCM.01938-07","volume":"46","author":"OJ Strauss","year":"2008","unstructured":"Strauss, O. J. et al. Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J. Clin. Microbiol. 46, 1514\u20131516 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrmicro2048_CR53","doi-asserted-by":"crossref","unstructured":"European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing\/W genotype Mycobacterium tuberculosis and drug resistance. Emerg. Infect. Dis. 12, 736\u2013743 (2006).","DOI":"10.3201\/eid1205.050400"},{"key":"BFnrmicro2048_CR54","first-page":"436","volume":"11","author":"YJ Sun","year":"2007","unstructured":"Sun, Y. J. et al. Genotype and phenotype relationships and transmission analysis of drug-resistant tuberculosis in Singapore. Intern. J. Tuberc. Lung Dis. 11, 436\u2013442 (2007).","journal-title":"Intern. J. Tuberc. Lung Dis."},{"key":"BFnrmicro2048_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1465-9921-6-134","volume":"6","author":"HS Cox","year":"2005","unstructured":"Cox, H. S. et al. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir. Res. 6, 134 (2005).","journal-title":"Respir. Res."},{"key":"BFnrmicro2048_CR56","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1128\/JCM.01291-06","volume":"44","author":"BJ Marais","year":"2006","unstructured":"Marais, B. J. et al. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J. Clin. Microbiol. 44, 3539\u20133543 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrmicro2048_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1046\/j.1365-2249.2003.02171.x","volume":"133","author":"B Lopez","year":"2003","unstructured":"Lopez, B. et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exper. Immunol. 133, 30\u201337 (2003).","journal-title":"Clin. Exper. Immunol."},{"key":"BFnrmicro2048_CR58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.femsim.2004.05.012","volume":"42","author":"OS Toungoussova","year":"2004","unstructured":"Toungoussova, O. S., Caugant, D. A., Sandven, P., Mariandyshev, A. O. & Bjune, G. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol. Med. Microbiol. 42, 281\u2013290 (2004).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"BFnrmicro2048_CR59","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1473-3099(07)70143-3","volume":"7","author":"S Blower","year":"2007","unstructured":"Blower, S. & Supervie, V. Predicting the future of XDR tuberculosis. Lancet Infect. Dis. 7, 443 (2007).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrmicro2048_CR60","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nm1110","volume":"10","author":"T Cohen","year":"2004","unstructured":"Cohen, T. & Murray, M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nature Med. 10, 1117\u20131121 (2004).","journal-title":"Nature Med."},{"key":"BFnrmicro2048_CR61","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nm1102","volume":"10","author":"SM Blower","year":"2004","unstructured":"Blower, S. M. & Chou, T. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nature Med. 10, 1111\u20131116 (2004).","journal-title":"Nature Med."},{"key":"BFnrmicro2048_CR62","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0140-6736(05)74812-1","volume":"365","author":"K DeRiemer","year":"2005","unstructured":"DeRiemer, K. et al. Does DOTS work in populations with drug-resistant tuberculosis? Lancet 365, 1239\u20131245 (2005).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR63","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0140-6736(05)74788-7","volume":"365","author":"MA Espinal","year":"2005","unstructured":"Espinal, M. A. & Dye, C. Can DOTS control multidrug-resistant tuberculosis? Lancet 365, 1206\u20131209 (2005).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR64","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/thx.2007.082354","volume":"63","author":"P Wu","year":"2008","unstructured":"Wu, P. et al. Age-period-cohort analysis of tuberculosis notifications in Hong Kong from 1961 to 2005. Thorax 63, 312\u2013316 (2008).","journal-title":"Thorax"},{"key":"BFnrmicro2048_CR65","first-page":"21","volume-title":"Clinical Tuberculosis","author":"C Dye","year":"2008","unstructured":"Dye, C. in Clinical Tuberculosis 4th edn (eds Davies, P. D. O., Barnes, P. F. & Gordon, S. B.) 21\u201341 (Hodder Arnold, London, 2008)."},{"key":"BFnrmicro2048_CR66","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/S0140-6736(98)03199-7","volume":"352","author":"C Dye","year":"1998","unstructured":"Dye, C., Garnett, G. P., Sleeman, K. & Williams, B. G. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 352, 1886\u20131891 (1998).","journal-title":"Lancet"},{"key":"BFnrmicro2048_CR67","first-page":"60","volume":"2","author":"K Styblo","year":"1991","unstructured":"Styblo, K. & Bumgarner, J. R. Tuberculosis can be controlled with existing technologies: evidence. Tubercul. Surveill. Res. Unit. Progress Report 2, 60\u201372 (1991).","journal-title":"Tubercul. Surveill. Res. Unit. Progress Report"},{"key":"BFnrmicro2048_CR68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/S0882-0546(03)00069-0","volume":"18","author":"EA Nardell","year":"2003","unstructured":"Nardell, E. A. Environmental infection control of tuberculosis. Semin. Respir. Infect. 18, 307\u2013319 (2003).","journal-title":"Semin. Respir. Infect."},{"issue":"Suppl. 1","key":"BFnrmicro2048_CR69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1086\/518661","volume":"196","author":"NN Bock","year":"2007","unstructured":"Bock, N. N., Jensen, P. A., Miller, B. & Nardell, E. Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J. Infect. Dis. 196 (Suppl. 1), 108\u2013113 (2007).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2048_CR70","unstructured":"World Health Organization. Tuberculosis infection control in the era of expanding care and treatment (WHO, Geneva, 2007)."},{"key":"BFnrmicro2048_CR71","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis (WHO, Geneva, 2006)."},{"key":"BFnrmicro2048_CR72","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1371\/journal.pmed.0050150","volume":"5","author":"FG Cobelens","year":"2008","unstructured":"Cobelens, F. G. et al. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med. 5, e150 (2008).","journal-title":"PLoS Med."},{"key":"BFnrmicro2048_CR73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/s-0028-1085702","volume":"29","author":"CD Mitnick","year":"2008","unstructured":"Mitnick, C. D., Appleton, S. C. & Shin, S. S. Epidemiology and treatment of multidrug resistant tuberculosis. Semin. Respir. Crit. Care Med. 29, 499\u2013524 (2008).","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"Suppl. 1","key":"BFnrmicro2048_CR74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1472-9792(08)70039-8","volume":"88","author":"AJ Nunn","year":"2008","unstructured":"Nunn, A. J., Phillips, P. P. & Gillespie, S. H. Design issues in pivotal drug trials for drug sensitive tuberculosis (TB). Tuberculosis (Edinb.) 88 (Suppl. 1), 85\u201392 (2008).","journal-title":"Tuberculosis (Edinb.)"},{"key":"BFnrmicro2048_CR75","first-page":"217","volume":"80","author":"MW Borgdorff","year":"2002","unstructured":"Borgdorff, M. W., Floyd, K. & Broekmans, J. F. Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull. World Health Organ. 80, 217\u2013227 (2002).","journal-title":"Bull. World Health Organ."},{"key":"BFnrmicro2048_CR76","volume-title":"Epidemiology of Tuberculosis","author":"K Styblo","year":"1991","unstructured":"Styblo, K. Epidemiology of Tuberculosis (KNCV Tuberculosis Foundation, The Hague, 1991)."},{"key":"BFnrmicro2048_CR77","doi-asserted-by":"crossref","unstructured":"China Tuberculosis Control Collaboration. The effect of tuberculosis control in China. Lancet 364, 417\u2013422 (2004).","DOI":"10.1016\/S0140-6736(04)16764-0"},{"key":"BFnrmicro2048_CR78","first-page":"1225","volume":"11","author":"C Dye","year":"2007","unstructured":"Dye, C., Ottmani, S., Laasri, L. & Bencheikh, N. The decline of tuberculosis epidemics under chemotherapy: a case study in Morocco. Int. J. Tuberc. Lung Dis. 11, 1225\u20131231 (2007).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"BFnrmicro2048_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/322777","volume":"184","author":"PG Suarez","year":"2001","unstructured":"Suarez, P. G. et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J. Infect. Dis. 184, 473\u2013478 (2001).","journal-title":"J. Infect. Dis."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2048","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:26:10Z","timestamp":1684455970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro2048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFnrmicro2048"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro2048","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}